SCHEMBL3014804

SCHEMBL3014804

CCOC(=O)c1c(CCc2ccncc2)c2cc(-c3cc(F)c(C)c(F)c3F)ccc2n1-c1ccc(OC2CCCC2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.34
ACACB O00763 1/20 0.33
MAPT P10636 3/20 0.32
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
TP53 P04637 1/20 0.32
THRB P10828 1/20 0.32
S1PR3 Q99500 1/20 0.32
CYP17A1 P05093 1/20 0.32
CYP21A2 P08686 1/20 0.32
CYP11B1 P15538 1/20 0.32
SSTR5 P35346 1/20 0.32
FFAR4 Q5NUL3 1/20 0.32
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
BTK Q06187 1/20 0.31
HRH3 Q9Y5N1 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3012527 0.86 PPARA (0.38) ACACBMAPTL3MBTL1ALDH1A1
SCHEMBL3013914 0.77 P2RY14 (0.37) PDE4BPDE4DFFAR4MAOAMAOB
SCHEMBL3003319 0.76 PPARG (0.38) FFAR4HRH3
SCHEMBL3010652 0.75 AKR1C3 (0.35) ACACBPDE4BPDE4DMAOAMAOB
SCHEMBL3112196 0.71 FAAH (0.36) PDE4BPDE4DCYP17A1CYP21A2CYP11B1
SCHEMBL3112189 0.71 FAAH (0.36) PDE4BPDE4DCYP17A1CYP21A2CYP11B1
SCHEMBL4701518 0.71 MAPT (0.44) MAPTTP53MAOAMAOBHRH3
SCHEMBL333883 0.71 FAAH (0.38) PDE4BPDE4DTHRBMAOAMAOB
SCHEMBL334231 0.70 PPARG (0.41) MAPTTP53THRB
SCHEMBL2997378 0.69 PTGES (0.37) L3MBTL1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100197687-A1 Indoles Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197687-A1 Indoles Useful in the Treatment of Inflammation IDO1, IDO2, TPH1 APP 1142/4885ACACB 3572/4885MAPT 68/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.